TickerFacts.

Fulgent Genetics, Inc. (FLGT): Share Repurchases

Annual figures by period end, from SEC filings.

$10.88M
Year ended 2025-12-31
$63.88M
Trailing 12 months to 2026-06-30
-47.3%
3-year compound annual growth
n/m
5-year compound annual growth
$74.34M2019-12-31: $21.0K2020-12-31: $62.0K2022-12-31: $74.34M2023-12-31: $25.06M2024-12-31: $225.0K2025-12-31: $10.88M$10.88M
2019-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$10.88Mn/m2026-02-27, From 2025-01-01
2024-12-31$225.0K-99.1%2026-02-27, From 2024-01-01
2023-12-31$25.06M-66.3%2026-02-27, From 2023-01-01
2022-12-31$74.34Mn/a2025-02-28, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31$62.0K+195.2%2021-03-08, From 2020-01-01
2019-12-31$21.0Kn/a2021-03-08, From 2019-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Fulgent Genetics, Inc. (FLGT)2025-12-31$10.88Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$0-100.0%
CareDx, Inc. (CDNA)2025-12-31$87.77Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$113.0Kn/a
Guardant Health, Inc. (GH)2025-12-31$45.01Mn/a
Quest Diagnostics Inc (DGX)2025-12-31$450.00M+198.0%
Labcorp Holdings Inc. (LH)2025-12-31$450.00M+79.9%

Compare FLGT, BLLN, CDNA, CAI side by side · Screen every company in Services-Medical Laboratories ↗